Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.83 USD | +0.34% | +4.69% | +36.61% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.61% | 2.43B | |
+14.09% | 3,189B | |
+11.00% | 87.18B | |
+6.51% | 78.95B | |
-10.70% | 55.02B | |
+23.70% | 47.3B | |
+32.92% | 46.79B | |
-25.15% | 46.35B | |
+80.89% | 42.08B | |
-5.92% | 25.86B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cellebrite DI Names Zohar Tadmor-Eilat Chief People Officer